Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Thrombocythemia, Essential 1Primary Myelofibrosis 1Polycythemia Vera 1Myelodysplastic Syndromes 1

Interventions

ruxolitinib 10fludarabine phosphate 5Whole-Body Irradiation 5Cyclophosphamide 5Tacrolimus 4Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 4Hydroxyurea 4bomedemstat 3Stem Cell Transplantation 3Specimen Handling 3Busulfan 3Biopsy 3Aspirin 3fludarabine 2Phlebotomy 2Methotrexate 2Melphalan 2Injections 2Azacitidine 2venetoclax 1veliparib 1umbralisib 1piperine 1pevonedistat 1methanesulfonic acid 1itacitinib 1iadademstat 1givinostat hydrochloride 1givinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Polycythemia Vera × demethoxycurcumin × 1 year × Clear all
NCT06063486 2026-03-27

Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms

University of Southern California

Phase 2 Recruiting
30 enrolled
Myeloid

Myelodysplastic Syndromes, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡